1. ALLA AKTIER
  2. NYHETER
  3. MEDIVIR

Medivir

Nyheter Medivir Nyheter alla bolag

BioStock: Medivir presents promising results in difficult-to-treat patient population

– We are particularly encouraged by the durable benefit, with patients remaining on treatment for much longer than expected. More than 10 months median time to progression is significantly longer than previously achieved with second-line treatment with Lenvima monotherapy or other treatment options, says Medivir's CEO Jens Lindberg.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/06/medivir-presents-promising-results-in-difficult-to-treat-patient-population/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Datum 2024-06-27, kl 10:00
Källa Cision
Affiliate
Investera som eToros bästa investerare! Med eToros CopyTrader™, kan du automatiskt kopiera andra investerares beslut. Hitta investerare som du tror på och kopiera deras investeringar i realtid. Inga extra avgifter tas ut för funktionen.
Copy Trading innebär inte investeringsrådgivning. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.